Literature DB >> 2567040

Serotonin and alcohol: interrelationships.

G D Tollefson1.   

Abstract

Alcoholism is a multifaceted medicosocial problem. Recent literature discusses a common dyad, alcoholism and anxiety. Both disorders are interdigitated with the brain amine serotonin (5-hydroxytryptamine, 5-HT). Direct 5-HT activation reportedly attenuates alcohol consumption, whereas depletion enhances use patterns. Acute alcohol consumption has also been associated with a transient rise, albeit eventual diminished 5-HT turnover. A variety of 5-HT models have confirmed this observation, e.g., reduced platelet 5-HT content, uptake, and cerebrospinal fluid (CSF) 5-hydroxyindoleacetic acid. Such altered characteristics of 5-HT secondary to chronic alcohol use may explain the frequent morbidity of anxiety and/or depression. Acute alcohol consumption is also associated with accumulation of the 5-HT aldehyde derivative 5-hydroxymethtryptoline. Thus, alcohol may induce the in vivo formation of aldehydes, e.g., beta-carbolines, that themselves possess high lipophilicity and psychotropic activity. Future investigation into 5-HT-specific pharmacologic probes in alcoholism will be interesting. Preliminary research has consistently demonstrated that 5-HT-enhancing agents (e.g., zimelidine or fluvoxamine) decrease alcohol consumption, preference, and short-term memory decrements. Thus, 5-HT appears to represent at least one common denominator for a spectrum of behavioral disorders including anxiety and alcoholism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567040     DOI: 10.1159/000284625

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  10 in total

1.  Reasons for drinking in relation to problem drinking behavior in a sample of Japanese high school students.

Authors:  K Yokoyama; M Nishikitani; S Araki
Journal:  Int J Behav Med       Date:  1999

Review 2.  5-HT1A partial agonists. What is their future?

Authors:  D A Glitz; R Pohl
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

3.  Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter.

Authors:  Ana Marin D Carneiro; Randy D Blakely
Journal:  J Biol Chem       Date:  2006-06-27       Impact factor: 5.157

4.  Chronic alcoholism in the absence of Wernicke-Korsakoff syndrome and cirrhosis does not result in the loss of serotonergic neurons from the median raphe nucleus.

Authors:  K G Baker; G M Halliday; J J Kril; C G Harper
Journal:  Metab Brain Dis       Date:  1996-09       Impact factor: 3.584

5.  The neurobiological markers of acute alcohol's subjective effects in humans.

Authors:  Raphael Hamel; Olivier Demers; Camille Boileau; Marie-Laurence Roy; Hugo Théoret; Pierre-Michel Bernier; Jean-Francois Lepage
Journal:  Neuropsychopharmacology       Date:  2022-06-14       Impact factor: 8.294

Review 6.  Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities.

Authors:  M Soyka
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

7.  Serotonin and alcohol-related brain damage.

Authors:  G Halliday; K Baker; C Harper
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

8.  Upregulation of serotonin transporter by alcohol in human dendritic cells: possible implication in neuroimmune deregulation.

Authors:  Dakshayani Kadiyala Babu; Alain Diaz; Thangavel Samikkannu; Kurapati V K Rao; Zainulabedin M Saiyed; Jose W Rodriguez; Madhavan P N Nair
Journal:  Alcohol Clin Exp Res       Date:  2009-07-01       Impact factor: 3.455

9.  Interaction of biogenic amine hormones with acetaldehyde.

Authors:  Sarah J Murrey; Arthur S Brecher
Journal:  Dig Dis Sci       Date:  2009-02-25       Impact factor: 3.199

10.  Methamphetamine facilitates ethanol-induced depressions in cerebellar Purkinje neurons of prazocin- or DSP4-treated rats.

Authors:  Y Wang; C H Jeng; J C Lin; J Y Wang
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.